Boston University
Modulating behavior deficits in Alzheimer’s disease models by targeting interneurons
Abstract
dc:description.abstractAlzheimer’s Disease (AD) is the most common form of dementia and a multifaceted challenge. AD is represented by cognitive decline, memory deficits, and diversification in behavior. The hallmark pathological characteristics of AD include amyloid-beta plaques and phosphorylated tau tangles; however, recent studies have explored the dysregulation of neuronal networks and its effect on behavior and memory deficits in AD mouse models (APP/PS1 mice). Here we investigate the role of amyloid pathology on interneurons using chemogenetics, behavioral testing, calcium imaging, and multiphoton and confocal microscopy. We show that APP/PS1 mouse models are more hyperactive than Wild-type (WT) mice and found that caffeine administered in WT mice mimic phenotypic behavior of APP/PS1 mice. Based on these findings, we use chemogenetics to target inhibitory somatostatin-expressing (SOM) interneurons to establish a comparison between spontaneity of excitatory and inhibitory interneurons in APP/PS1 mice. We found that hyperactive SOM interneurons were accompanied by decreased excitatory neuron activity in APP/PS1 mice, hypothesizing that inhibiting SOM restores brain-wide network dysfunction in mouse models.
Degree
thesis:*- Name thesis:degree_name
- Master of Science
- Level thesis:degree_level
- masters
- Discipline thesis:degree_discipline
- Medical Sciences
- Grantor
- Boston University
- Year dc:date.issued
- 2024
Author and committee
dc:creator, dc:contributor.*- Author dc:creator
-
- Abdallah, Sarena
- Advisor dc:contributor.advisor
-
- Bragdon, Beth
Subjects
dc:subject × 7Rights
- Language dc:language.iso
- en_US
Identifiers
dc:identifier.*- Handle dc:identifier.uri
- https://hdl.handle.net/2144/51381